IonQ, Inc. Closes Massive $2.0 Billion Underwritten Offering of Common Stock and Warrants

Executive Summary

On October 16, 2026, IonQ, Inc. ($IONQ) announced the closing of a substantial registered underwritten public offering executed pursuant to an underwriting agreement entered into on October 14, 2026, with J.P. Morgan Securities LLC as the sole underwriter.

The transaction represents a $2.0 billion gross capital raise, issuing 50 million underlying shares/pre-funded units alongside 100 million coverage warrants, representing a monumental injection of liquidity and a significant potential dilution event for existing shareholders.

---

Offering Structure & Terms

1. Securities Offered:

   • Common Stock: 20,500,000 shares of common stock (par value $0.0001 per share).
   • Pre-Funded Warrants: 29,500,000 pre-funded warrants to purchase up to 29,500,000 shares of common stock at a nominal remaining exercise price of $0.0001 per share.
   • Series C Warrants: 100,000,000 warrants to purchase up to 100,000,000 common shares.

2. Pricing & Unit Structure:

   • Each share of Common Stock or Pre-Funded Warrant was sold together with two Series C Warrants at a combined public offering price of $40.00.
   • Net purchase price to the underwriter: $39.8000 per Common Share and $39.7999 per Pre-Funded Warrant (yielding gross proceeds of $2.00 billion before expenses).
   • The securities were issued separately and not as bundled units.

3. Series C Warrant Terms:

   • Exercise Price: $69.46 per share (representing a premium of ~73.65% over the $40.00 offering unit price).
   • Exercisability: Exercisable immediately upon issuance through the 7-year anniversary of the issuance date.
   • Beneficial Ownership Limit: Standard 4.99% blocker (adjustable up to 9.99%).
   • Fundamental Transactions: Includes provisions for standard adjustments and a cash-out option based on Black-Scholes valuation upon certain corporate events.

---

Market & Dilution Impact

• Immediate Share Count Expansion: 50,000,000 shares/pre-funded warrants issued immediately increase the float.
• Overhang from Series C Warrants: If fully exercised, the 100,000,000 Series C warrants would generate an additional $6.946 billion in gross cash proceeds while expanding the share count by another 100 million shares.
• Capital Base: Provides IonQ with a fortified balance sheet to support long-term R&D, commercial scaling of quantum computing architectures, and strategic acquisitions.